skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: The actin cytoskeleton inhibits pore expansion during PIV5 fusion protein-promoted cell-cell fusion

Journal Article · · Virology
; ; ;  [1];  [2]
  1. Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington KY 40536 (United States)
  2. Mercer University School of Medicine, Division of Basic Medical Sciences, Macon, GA 31207 (United States)

Paramyxovirus fusion (F) proteins promote both virus-cell fusion, required for viral entry, and cell-cell fusion, resulting in syncytia formation. We used the F-actin stabilizing drug, jasplakinolide, and the G-actin sequestrant, latrunculin A, to examine the role of actin dynamics in cell-cell fusion mediated by the parainfluenza virus 5 (PIV5) F protein. Jasplakinolide treatment caused a dose-dependent increase in cell-cell fusion as measured by both syncytia and reporter gene assays, and latrunculin A treatment also resulted in fusion stimulation. Treatment with jasplakinolide or latrunculin A partially rescued a fusion pore opening defect caused by deletion of the PIV5 F protein cytoplasmic tail, but these drugs had no effect on fusion inhibited at earlier stages by either temperature arrest or by a PIV5 heptad repeat peptide. These data suggest that the cortical actin cytoskeleton is an important regulator of fusion pore enlargement, an energetically costly stage of viral fusion protein-mediated membrane merger.

OSTI ID:
21460264
Journal Information:
Virology, Vol. 404, Issue 1; Other Information: DOI: 10.1016/j.virol.2010.04.024; PII: S0042-6822(10)00274-6; Copyright (c) 2010 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; ISSN 0042-6822
Country of Publication:
United States
Language:
English